Ali Behbahani Insider Trading $NVRO NEVRO CORP
Get free email notifications about insider trading for Ali Behbahani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).
Ali Behbahani in NEVRO CORP
Trading Symbol: NVROIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Ali Behbahani: Director
Holdings: 5,390 shares
Current Value: $503,049
Latest Transaction: May 23 2018
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ali Behbahani in NEVRO CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 23 2018 | NVRO | NEVRO CORP | Behbahani Ali | Director | Grant | A | 0.00 | 3,785 | 0 | 5,390 | 1.6 K to 5.4 K (+235.83 %) |
May 23 2018 | NVRO | NEVRO CORP | Behbahani Ali | Director | Grant | A | 0.00 | 3,785 | 0 | 5,390 | 1.6 K to 5.4 K (+235.83 %) |
Sep 15 2017 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 8 | 0 | 1,605 | 1.6 K to 1.6 K (+0.50 %) |
Sep 15 2017 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 32 | 0 | 1,597 | 1.6 K to 1.6 K (+2.04 %) |
May 30 2017 | NVRO | NEVRO CORP | Behbahani Ali | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
May 30 2017 | NVRO | NEVRO CORP | Behbahani Ali | Director | Grant | A | 0.00 | 1,518 | 0 | 1,565 | 47 to 1.6 K (+3,229.79 %) |
Nov 15 2016 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 3 | 0 | 47 | 44 to 47 (+6.82 %) |
Nov 15 2016 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 19 | 0 | 44 | 25 to 44 (+76.00 %) |
May 20 2016 | NVRO | NEVRO CORP | Behbahani Ali | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
Dec 03 2015 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 3 | 0 | 25 | 22 to 25 (+13.64 %) |
Dec 03 2015 | NVRO | NEVRO CORP | Behbahani Ali | Director | Buy | J | 0.00 | 22 | 0 | 22 | 0 to 22 |
Jun 01 2015 | NVRO | NEVRO CORP | Behbahani Ali | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 | |
Nov 07 2014 | NVRO | NEVRO CORP | Behbahani Ali | Director | Option Exercise | A | 18.00 | 8,477 | 152,586 | 8,477 |
Page: 1